Skip to content

The effect of dexmedetomidine sedation on intracranial and cerebral perfusion pressures in patients with acute severe brain injury

The effect of dexmedetomidine sedation on intracranial and cerebral perfusion pressures in patients with acute severe brain injury

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2006-000660-89-FI
Enrollment
20
Registered
2006-02-20
Start date
2006-03-23
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute blunt traumatic brain injury with intracranial abnormalities on the initial computed tomography (CT) scan consistent with head trauma, initial Glasgow Coma Scale (GCS) score =8 or GCS score deteriorating to =8 within 24 hrs following injury and need for ICP monitoring (determined by the responsible neurosurgeon), intubation, mechanical ventilation and continuous sedation.

Interventions

Trade Name: Precedex Pharmaceutical Form: Intravenous infusion Trade Name: Propofol -Lipuro Pharmaceutical Form: Intravenous infusion

Sponsors

Timo Iirola
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026